Table 6. Effects of Schistosoma mansoni Infection on Response to HIV Vaccine in Mice.
Study | Study Design | Time Elapsed Between Vaccine and Assessment | Vaccine Response in Schistosome Infected | Overall Effects of S. mansoni on HIV Vaccine |
---|---|---|---|---|
Dzhivhuho 2018 [55] | Mice with and without Sm were given candidate HIV vaccines Some mice were treated with PZQ* pre-vaccine |
12 days post-vaccine (vaccinated 2 weeks after PZQ) | ↓ HIV-specific splenocyte IFN-ɣ and IL-2 secretion Partial restoration of IFN-ɣ and IL-2 after PZQ ↓ gp-140 IgG antibody production in Sm |
Impaired HIV-specific cellular immune response to HIV vaccine Cellular immune response was restored completely when PZQ treatment was provided at least 8 weeks prior to vaccination |
Da’dara 2006 [106] | Mice with and without Sm were given candidate HIV vaccines | 2 weeks | ↓ HIV-specific IFN-ɣ secretion by CD8+ T cells in Sm | |
Da’dara 2010 [107] | Mice with Sm, mice with prior Sm who were treated, and uninfected mice were given candidate HIV vaccines | 2 weeks post-vaccine (vaccinated 4 or 8 weeks after PZQ) | ↑ HIV-specific IFN-ɣ secretion by CD8+ T cells after PZQ (completely restored when vaccinated 8 weeks after PZQ) |
*PZQ = praziquantel